Proteomic Analysis of Emodin Treatment in Neuropathic Pain Reveals Dysfunction of the Calcium Signaling Pathway
| Autor: | Peng Chen, Dongsheng Lin, Chen Wang, Jinglian Qu, Zhibing Wu, Wenjing Wang, Cuiwen Song |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Calmodulin
Tropomyosin receptor kinase B Pharmacology emodin 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Western blot 030202 anesthesiology medicine Journal of Pain Research Protein kinase C Calcium signaling Original Research neuropathic pain medicine.diagnostic_test biology Kinase business.industry CCI Long-term potentiation Anesthesiology and Pain Medicine chemistry iTRAQ KEGG biology.protein Emodin business 030217 neurology & neurosurgery |
| Zdroj: | Journal of Pain Research |
| ISSN: | 1178-7090 |
| Popis: | Peng Chen,1 Dongsheng Lin,2 Chen Wang,2 Cuiwen Song,1 Wenjing Wang,1 Jinglian Qu,1 Zhibing Wu2 1Basic Medical School, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, People’s Republic of China; 2First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People’s Republic of ChinaCorrespondence: Zhibing WuDepartment of Neurology, First Clinical Medical College of Guangzhou University of Chinese Medicine, 12 Jichang Road, Guangzhou, Guangdong, People’s Republic of ChinaTel +86 020 36585577Email wuzhibing2021@126.comBackground: Neuropathic pain (NP) is a syndrome of pain mediated by distinct pathophysiological processes, and current treatments are not fully satisfactory. Emodin is an effective component of Chinese traditional medicine and has an alleviating effect on NP, but the pharmacological mechanism is not clear.Methods: We used isobaric tags for relative and absolute quantitation (iTRAQ) technique integrated with liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis to identify potential targets of emodin in a rat peripheral nerve chronic constriction injury (CCI) model.Results: A total of 177 differentially expressed proteins were identified among the sham group, CCI group, and emodin group, with a threshold of 1.2-fold change and a P value ≤ 0.05. Among them, 100 differentially expressed proteins (51 up-regulated and 49 down-regulated) were identified in the CCI group compared with sham group. Moreover, 108 differentially expressed proteins (65 up-regulated and 43 down-regulated) were identified in the emodin group with the CCI group as reference. The enrichment analysis of Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) revealed an important role of calcium signaling pathway, neurotransmitter regulation, and long-term potentiation (LTP) in emodin-treated CCI model. Real-time quantitative fluorescence PCR (qRT-PCR) and Western blot analysis revealed that emodin decreased expression of calcium signaling related proteins, including calmodulin (CaM) dependent protein kinase II (CaMK II), phospholipase Cβ 1 (PLCβ 1), protein kinase C (PKC), protein kinase C (PKA), and tropomyosin-related kinase B (TrkB), compared with the CCI group.Conclusion: Overall, these findings indicated that emodin might alleviate NP by regulating the calcium signaling pathway.Keywords: neuropathic pain, emodin, CCI, iTRAQ, KEGG |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|